-- Nichi-Iko Pharmaceutical to Buy 33.4% of Korea's Aprogen in Private Treaty
-- B y   G o   O n o m i t s u
-- 2010-10-20T23:39:23Z
-- http://www.bloomberg.com/news/2010-10-20/nichi-iko-pharmaceutical-to-acquire-one-third-of-south-korea-s-aprogen.html
Nichi-Iko Pharmaceutical Co. plans
to acquire 33.4 percent of South Koreaâ€™s Aprogen Inc. through a
private placement. The Japanese generic-drug maker made the
announcement in a release to the Tokyo Stock Exchange. The
Nikkei newspaper reported Nichi-Iko will spend about 1 billion
yen ($12 million) for the acquisition.  To contact the reporter on this story:
Go Onomitsu in Tokyo at 
 gonomitsu@bloomberg.net   To contact the editor responsible for this story:
Steven McPherson at 
 smcpherson@bloomberg.net  